1. bookVolume 60 (2022): Edition 2 (June 2022)
Détails du magazine
License
Format
Magazine
eISSN
2501-062X
Première parution
30 Mar 2015
Périodicité
4 fois par an
Langues
Anglais
access type Accès libre

Serum uric acid as a predictor of cardio- and cerebro-vascular diseases in maintenance hemodialysis patients

Publié en ligne: 14 Jun 2022
Volume & Edition: Volume 60 (2022) - Edition 2 (June 2022)
Pages: 115 - 122
Reçu: 31 Oct 2021
Détails du magazine
License
Format
Magazine
eISSN
2501-062X
Première parution
30 Mar 2015
Périodicité
4 fois par an
Langues
Anglais
Abstract

Background: Hyperuricemia is associated with an increased risk of cardio-and cerebrovascular disease (CVD) in general population. However, in the hemodialysis (HD) patients, low serum uric acid (SUA) increases the risk of mortality. Considering that CVD is the principal cause of death among maintenance HD patients, the present study aimed to determine the predictive value of SUA for CVD outcome in this population.

Methods: In this two-year follow-up prospective study, 205 outpatients under maintenance HD were enrolled from March 2017 to 2020. Patients’ demographic data, underlying diseases, and the results of serum tests, as well as two-year follow-up results of CVD events and mortality were recorded.

Results: A total of 130 (63%) patients were eligible for analysis; 62.9% were male; mean age of participants was 59±13years. At follow-up, coronary artery disease was observed in 43.2%, peripheral artery disease in 26.5%, and cerebrovascular disease in 20.5%; angiography was required in 52.3% and 4.5% died of CVD. SUA was ≤5.4 mg/dL in 52 patients, 5.5–6.1 mg/dL in 19, and ≥6.2 mg/dL in 59 patients with significant difference based on mean age, sex distribution, occurrence of cerebrovascular disease and cardiovascular mortality (P<0.05). Patients with cerebrovascular disease had a significantly lower SUA levels (P=0.006). Logistic regression showed the significant effect of SUA on the occurrence of cerebrovascular disease (P=0.008).

Conclusion: Low SUA can predict two-year incidence of cerebrovascular disease in HD patients. However, SUA levels did not show significant predictive effect on two-year coronary events, peripheral artery disease and cardiovascular mortality.

Keywords

1. JHA V, GARCIA-GARCIA G, ISEKI K, LI Z, NAICKER S, PLATTNER B, et al. Chronic kidney disease: global dimension and perspectives. The Lancet. 2013;382(9888):260–72.10.1016/S0140-6736(13)60687-XSearch in Google Scholar

2. CLARKSON KA, ROBINSON K. Life on dialysis: a lived experience. Nephrol Nurs J. 2010;37(1):29–35.Search in Google Scholar

3. CHUASUWAN A, POORIPUSSARAKUL S, THAKKINSTIAN A, INGSATHIT A, PATTANAPRATEEP O. Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. Health Qual. life outcomes. 2020;18(1):1–11.Search in Google Scholar

4. MOUSAVI SSB, SOLEIMANI A, MOUSAVI MB. Epidemiology of end-stage renal disease in Iran: a review article. Saudi J Kidney Dis Transpl. 2014;25(3):697–702.10.4103/1319-2442.13224224821181Search in Google Scholar

5. BELADI-MOUSAVI SS, ALEMZADEH-ANSARI MJ, ALEMZADEH-ANSARI MH, BELADI-MOUSAVI M. Long-term survival of patients with end-stage renal disease on maintenance hemodialysis: a multicenter study in Iran. Iran J Kidney Dis. 2012;6(6):452–56.Search in Google Scholar

6. COZZOLINO M, MANGANO M, STUCCHI A, CICERI P, CONTE F, GALASSI A. Cardiovascular disease in dialysis patients. Nephrol. Dial. Transplant. 2018;33(suppl_3): iii28–iii34.10.1093/ndt/gfy174616881630281132Search in Google Scholar

7. COUSER WG, REMUZZI G, MENDIS S, TONELLI M. The contribution of chronic kidney disease to the global burden of major no communicable diseases. Kidney Int. 2011;80(12):1258–70.10.1038/ki.2011.36821993585Search in Google Scholar

8. OSSAREH S, FARROKHI F, ZEBARJADI M. Survival of Patients on Hemodialysis and Predictors of Mortality: a Single-Centre Analysis of Time-Dependent Factors. Iran J Kidney Dis. 2016;10(6):369–80.Search in Google Scholar

9. SOLTANI Z, RASHEED K, KAPUSTA DR, REISIN E. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr. Hypertens. Rep. 2013;15(3):175–81.Search in Google Scholar

10. LATIF W, KARABOYAS A, TONG L, WINCHESTER JF, ARRINGTON CJ, PISONI RL, et al. Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population. Clin J Am Soc Nephrol. 2011;6(10):2470–77.10.2215/CJN.00670111335956221868616Search in Google Scholar

11. KIM CS, JIN D-C, YUN YC, BAE EH, MA SK, KIM SW. Relationship between serum uric acid and mortality among hemodialysis patients: Retrospective analysis of Korean end-stage renal disease registry data. Kidney Res Clin Pract. 2017;36(4):368–76.10.23876/j.krcp.2017.36.4.368574304629285429Search in Google Scholar

12. PARK C, OBI Y, STREJA E, RHEE CM, CATABAY CJ, VAZIRI ND, et al. Serum uric acid, protein intake and mortality in hemodialysis patients. Nephrol Dial Transplant. 2017;32(10):1750–57.10.1093/ndt/gfw419583768728064158Search in Google Scholar

13. BEBERASHVILI I, ERLICH A, AZAR A, SINUANI I, FELDMAN L, GORELIK O, et al. Longitudinal study of serum uric acid, nutritional status, and mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2016;11(6):1015–23.10.2215/CJN.10400915489175327026520Search in Google Scholar

14. LOVRE D, SHAH S, SIHOTA A, FONSECA VA. Managing diabetes and cardiovascular risk in chronic kidney disease patients. Endocrinol Metab Clin. 2018;47(1):237–57.10.1016/j.ecl.2017.10.006580613929407054Search in Google Scholar

15. MURRAY T, GOLDBERG M. Chronic interstitial nephritis: etiologic factors. Ann Intern Med. 1975;82(4):453–55.10.7326/0003-4819-82-4-4531119762Search in Google Scholar

16. BEBERASHVILI I, SINUANI I, AZAR A, SHAPIRO G, FELDMAN L, STAV K, et al. Serum uric acid as a clinically useful nutritional marker and predictor of outcome in maintenance hemodialysis patients. Nutr J. 2015;31(1):138–47.10.1016/j.nut.2014.06.01225466658Search in Google Scholar

17. FIRTH D. Bias Reduction of Maximum Likelihood Estimates. Biometrika 1993; 80(1):27–38.10.1093/biomet/80.1.27Search in Google Scholar

18. HEINZE G, PLONER M, DUNKLER D, SOUTHWORTH H, HEINZE MG. “Package ‘logistf” (2020).Search in Google Scholar

19. KUCIRKA LM, GRAMS ME, LESSLER J, HALL EC, JAMES N, MASSIE AB, et al. Association of race and age with survival among patients undergoing dialysis. JAMA. 2011;306(6):620–26.10.1001/jama.2011.1127393809821828325Search in Google Scholar

20. CHANDRASHEKAR A, RAMAKRISHNAN S, RANGARAJAN D. Survival analysis of patients on maintenance hemodialysis. Indian J Nephrol. 2014;24(4):206–13.10.4103/0971-4065.132985411933225097332Search in Google Scholar

21. ECKARDT K-U, KIM J, KRONENBERG F, ALJAMA P, ANKER SD, CANAUD B, et al. Hemoglobin variability does not predict mortality in European hemodialysis patients. J Am Soc Nephrol. 2010;21(10):1765–75.10.1681/ASN.2009101017301353420798262Search in Google Scholar

22. GOODKIN DA, FULLER DS, ROBINSON BM, COMBE C, FLUCK R, MENDELSSOHN D, et al. Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients. J Am Soc Nephrol. 2011;22(2):358–65.10.1681/ASN.2010020173302990821164028Search in Google Scholar

23. KREDIET RT, BALAFA O. Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol. 2010;6(8):451–60.10.1038/nrneph.2010.6820567248Search in Google Scholar

24. CHANG TI, STREJA E, SOOHOO M, KIM TW, RHEE CM, KOVESDY CP, et al. Association of serum triglyceride to HDL cholesterol ratio with all-cause and cardiovascular mortality in incident hemodialysis patients. Clin J Am Soc Nephrol. 2017;12(4):591–602.10.2215/CJN.08730816538338828193609Search in Google Scholar

25. RAJU D, LALITHA D, KIRANMAYI P. A study of lipid profile and lipid peroxidation in chronic kidney disease with special reference to hemodialysis. J Clinic Res Bioeth. 2013;4(1):1–5.10.4172/2155-9627.1000143Search in Google Scholar

26. MIKOLASEVIC I, ŽUTELIJA M, MAVRINAC V, ORLIC L. Dyslipidemia in patients with chronic kidney disease: etiology and management. Int J Nephrol Renovasc dis. 2017; 10:35–45.10.2147/IJNRD.S101808530497128223836Search in Google Scholar

27. ZHANG B, GAO C, YANG N, ZHANG W, SONG X, YIN J, et al. Is elevated SUA associated with a worse outcome in young Chinese patients with acute cerebral ischemic stroke? BMC Neurol. 2010;10(1):1–6.10.1186/1471-2377-10-82294960820849639Search in Google Scholar

28. CHIQUETE E, RUIZ-SANDOVAL JL, MURILLO-BONILLA LM, ARAUZ A, OROZCO-VALERA DR, OCHOA-GUZMÁN A, et al. Serum uric acid and outcome after acute ischemic stroke: PREMIER study. Cerebrovasc Dis. 2013;35(2):168–74.10.1159/00034660323446426Search in Google Scholar

Articles recommandés par Trend MD

Planifiez votre conférence à distance avec Sciendo